Published in Clin Endocrinol (Oxf) on October 06, 2008
Acromegaly pathogenesis and treatment. J Clin Invest (2009) 2.19
Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from acrostudy. Endocr Pract (2015) 1.46
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab (2014) 1.29
From somatostatin to octreotide LAR: evolution of a somatostatin analogue. Curr Med Res Opin (2009) 1.10
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial. J Clin Endocrinol Metab (2013) 1.06
Meta-analysis on the effects of octreotide on tumor mass in acromegaly. PLoS One (2012) 1.05
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas. BMC Endocr Disord (2010) 0.88
Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary (2011) 0.88
Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study. Pituitary (2014) 0.87
Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study. BMC Endocr Disord (2016) 0.86
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly. Pituitary (2016) 0.84
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary (2016) 0.83
Surgical interventions and medical treatments in treatment-naïve patients with acromegaly: systematic review and meta-analysis. J Clin Endocrinol Metab (2014) 0.80
Acromegaly: Beyond surgery. Indian J Endocrinol Metab (2013) 0.77
Patient-focussed outcomes in acromegaly. Pituitary (2014) 0.77
Management of acromegaly. F1000 Med Rep (2010) 0.76
Advancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease Paradigms. Front Surg (2016) 0.75
The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes. J Med Life (2016) 0.75
Current therapies and mortality in acromegaly. J Med Life (2015) 0.75
Critical appraisal of a randomized trial: surgery is superior to octreotide LAR in newly diagnosed patients with acromegaly. Clin Endocrinol (Oxf) (2009) 0.75
Male circumcision decreases penile sensitivity as measured in a large cohort. BJU Int (2013) 2.93
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet (2013) 2.83
Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med (2013) 2.66
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) (2006) 2.56
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2004) 2.45
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series. World Neurosurg (2012) 2.26
Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science (2006) 2.24
Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem (2006) 2.20
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med (2003) 2.09
The endoscopic endonasal approach for the management of craniopharyngiomas involving the third ventricle. Neurosurg Rev (2012) 2.06
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly. Clin Endocrinol (Oxf) (2007) 2.01
Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.. Radiology (2002) 1.96
Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation. J Clin Endocrinol Metab (2008) 1.94
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N Engl J Med (2014) 1.89
Using the Progress Test Medizin (PTM) for evaluation of the Medical Curriculum Munich (MeCuM). GMS Z Med Ausbild (2010) 1.79
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol (2003) 1.79
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension (2013) 1.76
Ketoconazole in Cushing's disease: is it worth a try? J Clin Endocrinol Metab (2014) 1.72
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol (2011) 1.69
Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab (2003) 1.67
The abducens nerve: microanatomic and endoscopic study. Neurosurgery (2007) 1.67
Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH. J Clin Endocrinol Metab (2004) 1.55
Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab (2013) 1.53
Endoscopic transsphenoidal approach: adaptability of the procedure to different sellar lesions. Neurosurgery (2002) 1.53
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab (2007) 1.53
Endoscopic endonasal surgery of the midline skull base: anatomical study and clinical considerations. Neurosurg Focus (2005) 1.53
KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension (2011) 1.51
90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol (2010) 1.49
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. Eur J Endocrinol (2012) 1.47
Extended endoscopic endonasal approach for selected pituitary adenomas: early experience. J Neurosurg (2010) 1.47
The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Dtsch Arztebl Int (2009) 1.46
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J Clin Endocrinol Metab (2010) 1.46
Intraoperative haemodynamic stability in patients with phaeochromocytoma--minimally invasive vs conventional open surgery. Clin Endocrinol (Oxf) (2006) 1.45
Intraventricular and skull base neuroendoscopy in 2012: a global survey of usage patterns and the role of intraoperative neuronavigation. World Neurosurg (2013) 1.45
Genetic determinants of serum testosterone concentrations in men. PLoS Genet (2011) 1.45
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors. Semin Nucl Med (2006) 1.44
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab (2008) 1.42
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab (2008) 1.41
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab (2007) 1.41
Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. J Clin Endocrinol Metab (2003) 1.41
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study. Eur J Haematol (2009) 1.40
Retroperitoneoscopic adrenalectomy: comparison of retrograde and antegrade approach among a series of 279 cases. Urology (2013) 1.40
The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes (2003) 1.39
Have 3D endoscopes succeeded in neurosurgery? Acta Neurochir (Wien) (2014) 1.39
The "suprasellar notch," or the tuberculum sellae as seen from below: definition, features, and clinical implications from an endoscopic endonasal perspective. J Neurosurg (2011) 1.39
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol (2002) 1.35
Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study. Stroke (2007) 1.34
Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med (2012) 1.32
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab (2005) 1.32
Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid (2005) 1.32
The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors. J Nucl Med (2012) 1.31
Pure endoscopic endonasal odontoidectomy: anatomical study. Neurosurg Rev (2007) 1.30
Extended endoscopic endonasal transsphenoidal approach for the removal of suprasellar tumors: Part 2. Neurosurgery (2007) 1.27
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab (2010) 1.24
A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet (2012) 1.23
The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab (2012) 1.23
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT. Radiology (2013) 1.22
[CME activities of medical journals: quality of multiple-choice questions as evaluation tool. Using the example of the German medical journals Deutsches Arzteblatt, Deutsche Medizinische Wochenschrift, and Der Internist]. Med Klin (Munich) (2007) 1.22
FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study. Transplantation (2007) 1.21
Integrating feedback from a clinical data warehouse into practice organisation. Int J Med Inform (2005) 1.20
Long-term assessment of the physical, mental, and sexual health among transsexual women. J Sex Med (2008) 1.17
High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2009) 1.17
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci U S A (2007) 1.16
Extended endoscopic endonasal approach to the pterygopalatine fossa: anatomical study and clinical considerations. Neurosurg Focus (2005) 1.16
HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res (2009) 1.16
86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion. Eur J Nucl Med Mol Imaging (2003) 1.15
Adrenal venous sampling: evaluation of the German Conn's registry. Hypertension (2011) 1.15
Endoscopic transnasal approach to the cavernous sinus versus transcranial route: anatomic study. Neurosurgery (2005) 1.14
Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab (2009) 1.14
Intracranial pressure in unresponsive chronic migraine. J Neurol (2014) 1.14
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab (2005) 1.13
Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab (2004) 1.12
Antimalarial and cytotoxic activities of ethnopharmacologically selected medicinal plants from South Vietnam. J Ethnopharmacol (2006) 1.12
AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. Eur J Endocrinol (2007) 1.12
Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol (2005) 1.11
Sexual and physical health after sex reassignment surgery. Arch Sex Behav (2005) 1.11
A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol (2004) 1.11
Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatry Res (2009) 1.10
A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet (2011) 1.10
Clinical review: Current scientific rationale for the use of somatostatin analogs and mTOR inhibitors in neuroendocrine tumor therapy. J Clin Endocrinol Metab (2011) 1.10
Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. J Clin Endocrinol Metab (2012) 1.10
A Novel Large-scale Mentoring Program for Medical Students based on a Quantitative and Qualitative Needs Analysis. GMS Z Med Ausbild (2011) 1.09
Skull base reconstruction in the extended endoscopic transsphenoidal approach for suprasellar lesions. J Neurosurg (2007) 1.08
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab (2015) 1.07
Tuberculum sellae meningiomas: high route or low route? A series of 51 consecutive cases. Neurosurgery (2008) 1.06
Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol (2005) 1.06
Endoscopic management of spontaneous meningoencephalocele of the lateral sphenoid sinus. J Neurosurg (2010) 1.06
Grades on the second medical licensing examination in Germany before and after the Licensing Reform of 2002: a study in two medical schools in Bavaria. Dtsch Arztebl Int (2010) 1.05
Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. Clin Endocrinol (Oxf) (2007) 1.05
Genital sensitivity after sex reassignment surgery in transsexual patients. Ann Plast Surg (2007) 1.04
Gender identity disorder in twins: a review of the case report literature. J Sex Med (2011) 1.04
Single brain metastases of carcinoid tumors. J Neurooncol (2004) 1.02
Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol (2009) 1.02
Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities. Magn Reson Imaging (2010) 1.01
Endoscopic transnasal resection of anterior cranial fossa meningiomas. Neurosurg Focus (2008) 1.00
Preliminary experience with a new three-dimensional computer-based model for the study and the analysis of skull base approaches. Childs Nerv Syst (2010) 0.99